<?xml version="1.0" encoding="UTF-8" standalone="yes"?><drugRecordsOutput><serviceExecutionTime>366</serviceExecutionTime><Drug id="10002"><DrugName>Kamikihi-to</DrugName><DrugSynonyms><Name><Value>Kamikihi-to</Value></Name></DrugSynonyms><CompanyOriginator id="17636">Kanebo KK</CompanyOriginator><CompaniesSecondary><Company id="17636">Kanebo KK</Company></CompaniesSecondary><CrossReferences><SourceEntity id="10002" type="Drug"><TargetEntity id="220663" type="siDrug">Kamikihi-To</TargetEntity></SourceEntity><SourceEntity id="17636" type="Company"><TargetEntity id="5035523340" type="organizationId">Kaigan Bell Management Ltd</TargetEntity></SourceEntity><SourceEntity id="364" type="ciIndication"><TargetEntity id="10020388" type="MEDDRA"/><TargetEntity id="D020249" type="MeSH"/><TargetEntity id="-411582485" type="omicsDisease"/><TargetEntity id="558" type="siCondition"/></SourceEntity><SourceEntity id="442" type="ciIndication"><TargetEntity id="10058490" type="MEDDRA"/><TargetEntity id="D018496" type="MeSH"/><TargetEntity id="-1649545996" type="omicsDisease"/><TargetEntity id="4057" type="siCondition"/></SourceEntity><SourceEntity id="65" type="ciIndication"><TargetEntity id="D020521" type="MeSH"/><TargetEntity id="-1815339002" type="omicsDisease"/><TargetEntity id="93" type="siCondition"/></SourceEntity></CrossReferences><PhaseHighest id="NDR">No Development Reported</PhaseHighest><PhaseTerminated id="DR">Discovery</PhaseTerminated><IndicationsSecondary><Indication id="364">Hormone deficiency</Indication><Indication id="442">Hyperoxia</Indication><Indication id="65">Stroke</Indication></IndicationsSecondary><Technologies><Technology id="762">Small molecule therapeutic</Technology></Technologies><LastModificationDate>2001-02-07T16:57:12.000Z</LastModificationDate><ChangeDateLast>2001-02-07T16:57:12.000Z</ChangeDateLast><AddedDate>1996-02-16T00:00:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;Kamihiki-to is an oriental herbal medicine which was being investigated by Kanebo for the treatment of stroke, hyperoxia and menopausal disorders [&lt;ulink linkType="reference" linkID="175613"&gt;175613&lt;/ulink&gt;]. However, no development has been reported by the company since 1997 [&lt;ulink linkType="reference" linkID="398050"&gt;398050&lt;/ulink&gt;].&lt;/para&gt;&lt;para&gt;Kamihiki-to ameliorated certain behavioral and physiological changes which occur in ovariectomized rats [&lt;ulink linkType="reference" linkID="175613"&gt;175613&lt;/ulink&gt;].&lt;/para&gt;&lt;/Summary&gt;</value></Summary></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="17636">Kanebo KK</Company><Country id="JP">Japan</Country><DevelopmentStatus id="NDR" sortOrder="3">No Development Reported</DevelopmentStatus><Indication id="65">Stroke</Indication><StatusDate>2001-02-06T00:00:00.000Z</StatusDate></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="17636">Kanebo KK</Company><Country id="JP">Japan</Country><DevelopmentStatus id="NDR" sortOrder="3">No Development Reported</DevelopmentStatus><Indication id="364">Hormone deficiency</Indication><StatusDate>2001-02-06T00:00:00.000Z</StatusDate></DevelopmentStatusCurrent><DevelopmentStatusCurrent><Company id="17636">Kanebo KK</Company><Country id="JP">Japan</Country><DevelopmentStatus id="NDR" sortOrder="3">No Development Reported</DevelopmentStatus><Indication id="442">Hyperoxia</Indication><StatusDate>2001-02-06T00:00:00.000Z</StatusDate></DevelopmentStatusCurrent><DevelopmentStatusHistoric><Company id="17636">Kanebo KK</Company><Country id="JP">Japan</Country><DevelopmentStatus id="DR" sortOrder="7">Discovery</DevelopmentStatus><Indication id="442">Hyperoxia</Indication><StatusDate>1995-09-01T00:00:00.000Z</StatusDate><Source id="175613" type="SERIAL"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="17636">Kanebo KK</Company><Country id="JP">Japan</Country><DevelopmentStatus id="DR" sortOrder="7">Discovery</DevelopmentStatus><Indication id="65">Stroke</Indication><StatusDate>1995-09-01T00:00:00.000Z</StatusDate><Source id="175613" type="SERIAL"/></DevelopmentStatusHistoric><DevelopmentStatusHistoric><Company id="17636">Kanebo KK</Company><Country id="JP">Japan</Country><DevelopmentStatus id="DR" sortOrder="7">Discovery</DevelopmentStatus><Indication id="364">Hormone deficiency</Indication><StatusDate>1995-09-01T00:00:00.000Z</StatusDate><Source id="175613" type="SERIAL"/></DevelopmentStatusHistoric></IDdbDevelopmentStatus><ReasonsForUpdate><ReasonForUpdate><Reason>Development Status Updated</Reason><Description>One or more development status entries have been updated</Description></ReasonForUpdate><ReasonForUpdate><Reason>Reference Added</Reason><Description>17 references added [&lt;ulink url="utility.reference?i_reference_id=176220" linkType="reference" linkID="176220"&gt;176220&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176223" linkType="reference" linkID="176223"&gt;176223&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176228" linkType="reference" linkID="176228"&gt;176228&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176242" linkType="reference" linkID="176242"&gt;176242&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176222" linkType="reference" linkID="176222"&gt;176222&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176232" linkType="reference" linkID="176232"&gt;176232&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176244" linkType="reference" linkID="176244"&gt;176244&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176221" linkType="reference" linkID="176221"&gt;176221&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176204" linkType="reference" linkID="176204"&gt;176204&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176230" linkType="reference" linkID="176230"&gt;176230&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176218" linkType="reference" linkID="176218"&gt;176218&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176224" linkType="reference" linkID="176224"&gt;176224&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176236" linkType="reference" linkID="176236"&gt;176236&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=398050" linkType="reference" linkID="398050"&gt;398050&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176248" linkType="reference" linkID="176248"&gt;176248&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=175613" linkType="reference" linkID="175613"&gt;175613&lt;/ulink&gt;, &lt;ulink url="utility.reference?i_reference_id=176215" linkType="reference" linkID="176215"&gt;176215&lt;/ulink&gt;]							</Description></ReasonForUpdate><ReasonForUpdate><Reason>Indexing Updated</Reason><Description>Indexing updated</Description></ReasonForUpdate><ReasonForUpdate><Reason>Editorial Amendments</Reason><Description>Minor editorial amendment</Description></ReasonForUpdate></ReasonsForUpdate><hasSWOTs>N</hasSWOTs></Drug><Drug id="100022"><DrugName>HTB-005</DrugName><DrugSynonyms><Name><Value>HTB-005</Value><Types><Type>Research Code</Type></Types></Name></DrugSynonyms><CompanyOriginator id="22606">Hyundai Pharmaceutical</CompanyOriginator><CompaniesSecondary><Company id="22606">Hyundai Pharmaceutical</Company></CompaniesSecondary><CrossReferences><SourceEntity id="22606" type="Company"><TargetEntity id="4295881051" type="organizationId">Hyundai Pharmaceutical Co Ltd</TargetEntity></SourceEntity><SourceEntity id="13" type="ciIndication"><TargetEntity id="10001760" type="MEDDRA"/><TargetEntity id="D000505" type="MeSH"/><TargetEntity id="-1648289448" type="omicsDisease"/><TargetEntity id="469" type="siCondition"/></SourceEntity></CrossReferences><PhaseHighest id="NDR">No Development Reported</PhaseHighest><PhaseTerminated id="DR">Discovery</PhaseTerminated><IndicationsSecondary><Indication id="13">Alopecia</Indication></IndicationsSecondary><ActionsSecondary><Action id="59620">Unspecified drug target</Action></ActionsSecondary><Technologies><Technology id="762">Small molecule therapeutic</Technology></Technologies><LastModificationDate>2018-04-02T03:20:48.000Z</LastModificationDate><ChangeDateLast>2018-04-02T00:00:00.000Z</ChangeDateLast><AddedDate>2015-11-26T00:00:00.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;As no development has been reported for some time, this program is assumed to be discontinued.&lt;/para&gt;&lt;para&gt;&lt;ulink linkID="22606" linkType="Company"&gt;Hyundai Pharma&lt;/ulink&gt; was investigating HTB-005,  for the potential treatment of alopecia. In November 2015, the drug was in preclinical development [&lt;ulink linkID="1710896" linkType="Reference"&gt;1710896&lt;/ulink&gt;].&lt;/para&gt;&lt;/Summary&gt;</value></Summary></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="22606">Hyundai Pharmaceutical</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="NDR" sortOrder="3">No Development Reported</DevelopmentStatus><Indication id="13">Alopecia</Indication><StatusDate>2018-03-31T00:00:00.000Z</StatusDate></DevelopmentStatusCurrent><DevelopmentStatusHistoric><Company id="22606">Hyundai Pharmaceutical</Company><Country id="KR">South Korea</Country><DevelopmentStatus id="DR" sortOrder="7">Discovery</DevelopmentStatus><Indication id="13">Alopecia</Indication><StatusDate>2015-11-06T00:00:00.000Z</StatusDate><Source id="1710896" type="CORPORATE"/></DevelopmentStatusHistoric></IDdbDevelopmentStatus><ReasonsForUpdate><ReasonForUpdate><Reason>Development Status Updated</Reason><Description>One or more development status entries have been updated</Description></ReasonForUpdate><ReasonForUpdate><Reason>Reference Added</Reason><Description>1 reference added [&lt;ulink url="utility.reference?i_reference_id=1710896" linkType="reference" linkID="1710896"&gt;1710896&lt;/ulink&gt;]							</Description></ReasonForUpdate><ReasonForUpdate><Reason>Indexing Updated</Reason><Description>Indexing updated</Description></ReasonForUpdate></ReasonsForUpdate><hasSWOTs>N</hasSWOTs></Drug></drugRecordsOutput>